Meta-Analysis Comparing Percutaneous Coronary Revascularization Using Drug-Eluting Stent Versus Coronary Artery

Kongyong Cui1, Dongfeng Zhang1, Shuzheng Lyu1

  • 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.

Insights

Coronary artery bypass grafting (CABG) is superior to drug-eluting stents (DES) for patients with left ventricular systolic dysfunction. CABG reduces mortality and myocardial infarction risk compared to DES in this vulnerable population.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Left ventricular (LV) systolic dysfunction poses challenges for revascularization strategies.
  • The comparative safety and efficacy of percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary artery bypass grafting (CABG) in these patients remain debated.

Purpose of the Study:

  • To conduct a meta-analysis identifying the optimal revascularization strategy for patients with coronary artery disease and LV systolic dysfunction.
  • To compare all-cause mortality, cardiac mortality, myocardial infarction, repeat revascularization, and stroke rates between PCI with DES and CABG.

Main Methods:

  • Comprehensive meta-analysis of adjusted observational studies published between January 2003 and March 2018.
  • Inclusion of 8 studies with 10,268 patients.
  • Utilized random-effect modeling to estimate pooled hazard ratios (HRs) and 95% confidence intervals (CIs) for primary endpoint of all-cause death.

Main Results:

  • PCI with DES was associated with significantly higher risks of all-cause mortality (HR 1.36), cardiac mortality (HR 2.20), myocardial infarction (HR 1.69), and repeat revascularization (HR 4.95) compared to CABG.
  • Similar outcomes were observed in subgroups with LV ejection fraction <35% or left main/multivessel disease.
  • Stroke rates were comparable between the two interventions (HR 0.92).

Conclusions:

  • Coronary artery bypass grafting (CABG) demonstrates superior outcomes compared to percutaneous coronary intervention (PCI) with drug-eluting stents (DES) in patients with coronary artery disease and LV systolic dysfunction.
  • CABG is particularly advantageous for patients with severe LV systolic dysfunction or complex coronary anatomy (left main and/or multivessel disease).
  • These findings suggest CABG as the preferred revascularization strategy for this high-risk patient group.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
471
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
273
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
383
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
696
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.3K